Findings from National Cancer Institute (NCI) in Biomedicine Reported (Characterization of a Compound Heterozygous SLC2A9 Mutation That Causes Hypouricemia)

MLA

“Findings from National Cancer Institute (NCI) in Biomedicine Reported (Characterization of a Compound Heterozygous SLC2A9 Mutation That Causes Hypouricemia).” Cancer Weekly, 12 Oct. 2021, p. 125. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.678557183&authtype=sso&custid=ns315887.

APA

Findings from National Cancer Institute (NCI) in Biomedicine Reported (Characterization of a Compound Heterozygous SLC2A9 Mutation That Causes Hypouricemia). (2021, October 12). Cancer Weekly, 125.

Chicago

Cancer Weekly. 2021. “Findings from National Cancer Institute (NCI) in Biomedicine Reported (Characterization of a Compound Heterozygous SLC2A9 Mutation That Causes Hypouricemia),” October 12. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.678557183&authtype=sso&custid=ns315887.